Amar Natarajan is the Ruth Branham Professor at the Eppley Institute for Research in Cancer and Allied Diseases and is the co-leader of the Targets, Modulators and Delivery Program, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center (UNMC), Omaha NE. He also holds courtesy appointments in the departments of Genetics, Cell Biology and Anatomy, and Pharmaceutical Sciences at UNMC. He received a B.S. in Chemistry at the Madras Christian College and earned his M.S. in Chemistry at the Indian Institute of Technology, Madras, India. He obtained a Ph.D. in Chemistry at the University of Vermont, Burlington, VT, USA. Following his postdoctoral training at the Harvard Medical School, Cambridge, MA, USA., in 2005, he started his independent career as an assistant professor at the University of Texas Medical Branch, Galveston TX, USA. He moved to the UNMC in 2009 as an associate professor and was promoted to full professor in 2014. His leadership in research and mentoring was recognized by the Research Leadership Award UNMC in 2020. He also served as a Panel member of the Drug Discovery and Pharmacology (DMP) study section at NIH from 2016 to 2020.
